| scholarly article | Q13442814 |
| P2093 | author name string | Ping-Yee Law | |
| Horace H Loh | |||
| Cherkaouia Kibaly | |||
| Hong-Yiou Lin | |||
| P2860 | cites work | Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice | Q24674933 |
| Transduction of receptor signals by beta-arrestins | Q28246395 | ||
| The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence | Q28260467 | ||
| A dopamine D2 receptor mutant capable of G protein-mediated signaling but deficient in arrestin binding | Q28569075 | ||
| Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence | Q28590279 | ||
| Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization | Q33708526 | ||
| Mu opioid analgesia and analgesic tolerance in two mouse strains: C57BL/6 and 129/SvJ. | Q33923659 | ||
| Molecular mechanisms and regulation of opioid receptor signaling | Q33932163 | ||
| Animal research: reporting in vivo experiments: the ARRIVE guidelines | Q34116755 | ||
| Activation of protein kinase C (PKC)α or PKCε as an approach to increase morphine tolerance in respiratory depression and lethal overdose | Q34121723 | ||
| Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications | Q34410429 | ||
| The expression of calcitonin gene-related peptide in dorsal horn neurons of the mouse lumbar spinal cord | Q73691374 | ||
| Descending control of pain | Q34659433 | ||
| Functionally selective signaling for morphine and fentanyl antinociception and tolerance mediated by the rat periaqueductal gray | Q34680703 | ||
| Modulating micro-opioid receptor phosphorylation switches agonist-dependent signaling as reflected in PKCepsilon activation and dendritic spine stability. | Q34752640 | ||
| G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal | Q35046020 | ||
| Spinal delivery of analgesics in experimental models of pain and analgesia | Q35205465 | ||
| Morphine-activated opioid receptors elude desensitization by beta-arrestin | Q36280218 | ||
| Morphine desensitization and cellular tolerance are distinguished in rat locus ceruleus neurons | Q36335620 | ||
| Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness | Q36514037 | ||
| Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. | Q36591603 | ||
| Quantitative encoding of the effect of a partial agonist on individual opioid receptors by multisite phosphorylation and threshold detection | Q36763815 | ||
| Morphine-induced mu-opioid receptor rapid desensitization is independent of receptor phosphorylation and beta-arrestins | Q36984756 | ||
| Efficacy of opioids for chronic pain: a review of the evidence | Q37198520 | ||
| The third intracellular loop of alpha 2-adrenergic receptors determines subtype specificity of arrestin interaction | Q38363402 | ||
| The subtleties of µ-opioid receptor phosphorylation | Q38464911 | ||
| Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies | Q38464958 | ||
| Guidelines for reporting experiments involving animals: the ARRIVE guidelines | Q39512979 | ||
| Comparison of four narcotic analgesics for extradural analgesia | Q39564414 | ||
| Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. | Q39949256 | ||
| Dextromethorphan potentiates morphine-induced antinociception at both spinal and supraspinal sites but is not related to the descending serotoninergic or adrenergic pathways. | Q40461707 | ||
| Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo | Q40682749 | ||
| Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization. | Q40817051 | ||
| Direct and differential interaction of beta-arrestins with the intracellular domains of different opioid receptors. | Q40819630 | ||
| Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
| Morphine activates opioid receptors without causing their rapid internalization | Q41175884 | ||
| Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells | Q41290918 | ||
| Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. | Q41348392 | ||
| Pain measurement: an overview | Q41384635 | ||
| A review of the use of fentanyl analgesia in the management of acute pain in adults | Q43070474 | ||
| Identification of two C-terminal amino acids, Ser(355) and Thr(357), required for short-term homologous desensitization of mu-opioid receptors | Q44068278 | ||
| Development of tolerance and sensitization to different opioid agonists in rats | Q44330007 | ||
| Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors | Q44340828 | ||
| Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice | Q44340971 | ||
| Mu-opioid receptor desensitization: role of receptor phosphorylation, internalization, and representation | Q44342223 | ||
| The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia | Q44345741 | ||
| Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. | Q44350174 | ||
| Cellular morphine tolerance produced by βarrestin-2-dependent impairment of μ-opioid receptor resensitization. | Q44350690 | ||
| Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats. | Q44639285 | ||
| Determination of the role of conventional, novel and atypical PKC isoforms in the expression of morphine tolerance in mice | Q44923198 | ||
| Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, beta 2-adrenergic, and m2 muscarinic cholinergic receptors | Q50337370 | ||
| A method to perform direct transcutaneous intrathecal injection in rats. | Q50767149 | ||
| Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice | Q51711835 | ||
| Letter: Duration of action of fentanyl. | Q52727577 | ||
| Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. | Q54651658 | ||
| Chapter 13 Descending inhibitory systems | Q58251673 | ||
| [Met]enkephalin in the spinal cord is involved in the antinociception induced by intracerebroventricularly-administered etorphine in the mouse | Q73667413 | ||
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 153-168 | |
| P577 | publication date | 2017-02-04 | |
| P1433 | published in | Pharmacological Research | Q15724622 |
| P1476 | title | Spinal or supraspinal phosphorylation deficiency at the MOR C-terminus does not affect morphine tolerance in vivo. | |
| P478 | volume | 119 |
| Q38640572 | Src-dependent phosphorylation of μ-opioid receptor at Tyr(336) modulates opiate withdrawal | cites work | P2860 |
Search more.